about
Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials ArchiveApplying openEHR's Guideline Definition Language to the SITS international stroke treatment registry: a European retrospective observational studyMultivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).Thrombolytic therapy for acute stroke in Austria: data from the Safe Implementation of Thrombolysis in Stroke (SITS) register.Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data.Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes.Intravenous thrombolysis in ischemic stroke patients with isolated homonymous hemianopia: analysis of Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.Trends in Door-to-Thrombolysis Time in the Safe Implementation of Stroke Thrombolysis Registry: Effect of Center Volume and Duration of Registry Membership.Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation.How common is isolated dysphasia among patients with stroke treated with intravenous thrombolysis, and what is their outcome? Results from the SITS-ISTR.IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry.Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus.Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register.Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.Reciprocal Interaction of 24-Hour Blood Pressure Variability and Systolic Blood Pressure on Outcome in Stroke Thrombolysis.Thrombectomy in acute ischemic stroke: estimations of increasing demands.Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.Clinical Selection Strategies to Identify Ischemic Stroke Patients With Large Anterior Vessel Occlusion: Results From SITS-ISTR (Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry).Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis.Why does Sweden have the lowest childhood injury mortality in the world? The roles of architecture and public pre-school services.External Validation of the ASTRAL and DRAGON Scores for Prediction of Functional Outcome in Stroke.Changes in European Label and Guideline Adherence After Updated Recommendations for Stroke Thrombolysis: Results From the Safe Implementation of Treatments in Stroke Registry.Mobile Phone-Based Questionnaire for Assessing 3 Months Modified Rankin Score After Acute Stroke: A Pilot Study.Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis.Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).Thrombolysis for acute stroke in Australia: outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008).Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.High initial blood pressure after acute stroke is associated with poor functional outcome.Benefit of thrombolysis for stroke is maintained around the clock: results from the SITS-EAST Registry.Within-day and weekly variations of thrombolysis in acute ischemic stroke: results from safe implementation of treatments in stroke-international stroke thrombolysis register.Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke.Safe implementation of thrombolysis in stroke-monitoring study in Italy.Epilepsy and injury mortality in Sweden--the importance of changes in coding practice.Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITSalivary cortisol, a biological marker of stress, is positively associated with 24-hour systolic blood pressure in patients with acute ischaemic stroke.Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.
P50
Q28748178-F6C2E38D-9448-4140-A4F0-38F0AE2589B5Q30834465-D1A231C5-AF47-43DE-BD63-0494C57D49BAQ33377421-4DF7BE06-4822-42F8-9935-B0FC7723A911Q33632565-D9F24701-3CC2-4AF9-83F0-0591D02DC67CQ33974789-7A39E7FF-E8A7-41E2-8976-369C9A9DA99DQ34189656-014DC757-975E-4E39-9D60-C24D2C216ED9Q34343420-C16B016D-F469-4BCF-A67F-CBF8D06BA0FBQ35209739-A004A164-AB74-417E-B48E-4934913F5123Q35591355-428A490C-0ACC-4F55-AEDF-9D7604623C15Q35615757-059F7493-56B6-4934-B789-D313EE10A5C9Q35653269-2F65EDFF-4DFC-4257-AB9D-AAD74A81517AQ36329219-007EF236-1B15-4F67-A79D-5B56460D187CQ36405870-EBBAA1F5-7470-4A9F-AD67-1461F39A42B7Q38407002-CECB1A06-85EC-4FDF-83A2-83C184A76181Q38440967-19D32C6E-447D-497E-9E6F-E85497F86A66Q38642376-4B85E339-68D1-4744-A526-1E7FEBBD12A1Q38762866-692FB781-7FA6-4BCD-B0D8-61FDEA8A1F7EQ38827336-133A9AF3-CA7B-4CBC-B231-DC3EC9369E19Q38973346-5C41C69C-7ADF-4E65-8FEB-2CE2891EA157Q39020931-95D848D0-0D95-42D9-A10C-FA5DD70EB1C4Q39175002-C5DB389E-B699-4D8C-99FA-0AFAE639C552Q39768092-B01A4D17-29D4-4928-BDB0-620681C1AED9Q39770133-2403FE5D-3B88-4114-A1F0-34EA317692E7Q40377800-0BE56EDD-0377-46E1-8E9F-AB02F1A1F474Q41170336-EC3642B0-58A7-4D76-B9B4-FC92D4F7F710Q41243045-7D8F7B3D-A061-4C47-AB32-AF6646A22CDEQ41583141-75D7F90C-ACBB-4D3F-8B37-36DBE39F6611Q42610437-F30BFDFA-D5D6-4372-9DD5-5CFE197AC251Q42675050-4875D9D3-2C35-4C2A-B4F4-2F3E791919C3Q42855678-B8EA0416-2EE5-4507-A478-01BD959E6D10Q43199823-698484A2-21E0-48D9-ADD6-AA4A5D5FDABAQ43605956-D95E588A-E0E8-4DAB-A75C-3420726795DDQ43767033-DCA7AA49-2BF0-4785-BDE6-CAFC92A31748Q43783631-FCA81EDB-8EC1-4DCF-AFE8-11E526D3D33AQ43818138-1722A344-541F-41E4-A67B-ABDD5E961130Q44197349-BCBFE335-1893-4D1A-AE2C-3D11B198B428Q44203059-6917979B-22F5-4836-B59E-4198B064D6E6Q44547151-CEB093F3-92E6-4CB2-94AA-FDC071F69688Q44992611-36CEFE22-1157-4747-AD89-CF7558F844E9Q46120261-33E88382-0A9D-4922-B00D-E475AF71CAFC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Niaz Ahmed
@ast
Niaz Ahmed
@en
Niaz Ahmed
@es
Niaz Ahmed
@nl
Niaz Ahmed
@sl
নিয়াজ আহমেদ
@bn
type
label
Niaz Ahmed
@ast
Niaz Ahmed
@en
Niaz Ahmed
@es
Niaz Ahmed
@nl
Niaz Ahmed
@sl
নিয়াজ আহমেদ
@bn
prefLabel
Niaz Ahmed
@ast
Niaz Ahmed
@en
Niaz Ahmed
@es
Niaz Ahmed
@nl
Niaz Ahmed
@sl
নিয়াজ আহমেদ
@bn
P214
P906
P1053
G-6717-2013
P106
P213
0000 0000 5379 284X
P214
P31
P3829
P496
0000-0001-7970-0146
P569
1969-01-01T00:00:00Z
P7859
viaf-31972157